📝 SummarXiv

Abstract

Ratio-based biomarkers -- such as the proportion of necrotic tissue within a tumor -- are widely used in clinical practice to support diagnosis, prognosis, and treatment planning. These biomarkers are typically estimated from soft segmentation outputs by computing region-wise ratios. Despite the high-stakes nature of clinical decision making, existing methods provide only point estimates, offering no measure of uncertainty. In this work, we propose a unified confidence-aware framework for estimating ratio-based biomarkers. Our uncertainty analysis stems from two observations: i) the probability ratio estimator inherently admits a statistical confidence interval regarding local randomness (bias and variance), ii) the segmentation network is not perfectly calibrated. We conduct a systematic analysis of error propagation in the segmentation-to-biomarker pipeline and identify model miscalibration as the dominant source of uncertainty. We leverage tunable parameters to control the confidence level of the derived bounds, allowing adaptation towards clinical practice. Extensive experiments show that our method produces statistically sound confidence intervals, with tunable confidence levels, enabling more trustworthy application of predictive biomarkers in clinical workflows.